PI
LKFT

PEAK6 Investments’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

PEAK6 Investments’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,443
Closed -$452K – 3625
2019
Q3 		$373K Buy
+2,443
New +$400K ﹤0.01% 2489

Other funds holding LKFT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

PEAK6 Investments's LKFT Position: Q4 2019 in Review

PEAK6 Investments sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2019, closing a stake of 2,443 shares — an estimated $452K sold.

PEAK6 Investments first reported a position in LKFT in Q3 2019 and held it in 1 quarter. The position peaked at $373K in Q3 2019. 137 funds tracked by Wall St. Rank hold LKFT as of Q4 2019.

  • PEAK6 Investments reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2019 after selling out during the quarter.
  • PEAK6 Investments sold 2,443 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2019, an estimated $452K.
  • PEAK6 Investments first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2019 and held it in 1 quarter.
  • PEAK6 Investments's Lakefront Biotherapeutics American Depositary Shares position peaked at $373K in Q3 2019.
  • 137 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2019.

Based on PEAK6 Investments's 13F filing for Q4 2019, filed 13 Feb 2020.